Skip to content

Effect of a a novel curcumin-galactomannoside complex (CGM)delivery syste on Improvement of liver function markers in chronic alcoholic patients.

A pilot Clinical study to assess the effect of Curcumin supplementation (CurQfen-The enhanced bioavailable formulation of curcumin)on liver health in chronic drinkers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012385
Enrollment
48
Registered
2018-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CurQfen: 250mg capsules 2 times in a day for 56 days Control Intervention1: Placebo: 250mg capsules 2 times in a day for 56 days

Sponsors

Akay Flavours And Aromatics Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Chronic alcohol intake of more than six units per week. 1 unit is equal to 150 ml of wine or 360 ml of beer or 45 ml of 40 percentage alcohol 2.Mild to moderate cases of alcoholic hepatitis 3.Ratio of AST to ALT greater than 2 4.Informed consent

Exclusion criteria

Exclusion criteria: 1.Present with kidney failure (serum creatinine > 2.0 mg/dl) or in the process of renal dialysis 2.Present with Viral hepatitis (ALT level >/equal to 3 times the upper limit) 3.Receive any herbal medications or curcumin 4.Subjects abstaining from alcohol for more than 1 month 5. concomitant symptomatic or asymptomatic bacterial infection and severe bacterial infection within the previous 3 months. 6.Pregnancy or breastfeeding 7.Have a history of gall bladder diseases or removal

Design outcomes

Primary

MeasureTime frame
- reduction in liver enzymes - Changes in anti inflammatory markers - Changes in Antioxidant parametersTimepoint: Day 0, Day 56

Secondary

MeasureTime frame
- Changes in Lipid Profile - Changes in Safety parameters/ Adverse eventsTimepoint: Day 0, Day 56

Countries

India

Contacts

Public ContactJestin V Thomas

Akay Flavours and Aromatics Pvt.Ltd

Krishnakumar.IM@akay-group.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 23, 2026